Atlas Trials

Safety and Efficacy Study of Ozurdex® Compared to Lucentis® in Patients With Branch Retinal Vein Occlusion

Clinical trial NCT01427751 · COMPLETED

Trial details

NCT number
NCT01427751
Sponsor
Allergan
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Retinal Vein OcclusionMacular Edema
Start date
2011-10-11
Primary completion
2014-11-04
Enrollment
307

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.